Nathalie V. Fernández Villalobos
YOU?
Author Swipe
View article: Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South Africa
Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South Africa Open
Among 130 992 people with HIV (PWH) in South Africa, 60 anal cancers were diagnosed. Lower CD4 counts and, to a lesser extent, higher HIV RNA viral loads were associated with an increased anal cancer risk. Maintaining high CD4 counts may c…
View article: Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South Africa
Immunodeficiency, HIV Viremia, and Incident Anal Cancer Among People With HIV in South Africa Open
Among 130 992 people with HIV (PWH) in South Africa, 60 anal cancers were diagnosed. Lower CD4 counts and, to a lesser extent, higher HIV RNA viral loads were associated with an increased anal cancer risk. Maintaining high CD4 counts may c…
View article: Anal Cancer Incidence Rates Among Men and Women With and Without HIV in South Africa
Anal Cancer Incidence Rates Among Men and Women With and Without HIV in South Africa Open
Background More than 7.5 million people in South Africa have HIV, but little is known about the association of HIV and anal cancer incidence. We examined anal cancer incidence in a large South African cohort of insured men and women. Metho…
View article: Scale of differentiated service delivery implementation in HIV care facilities in low‐ and middle‐income countries: a global facility survey
Scale of differentiated service delivery implementation in HIV care facilities in low‐ and middle‐income countries: a global facility survey Open
Introduction In 2016, the World Health Organization recommended differentiated service delivery (DSD) as a client‐centred approach to simplify HIV care in frequency and intensity, thus reducing the clinic visit burden on individuals and HI…
View article: Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S6 shows rate ratios for prostate specific antigen (PSA) testing and prostate biopsies, excluding HIV positive men not in Aid for AIDS registration.
View article: Figure 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Figure 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Prostate cancer diagnosis rates by age and HIV status. The figure shows estimated prostate cancer diagnosis rates per 100,000 person-years by age (years) among men with and without HIV. The shaded areas represent 95% CIs.
View article: Table S5 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S5 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S5 shows characteristics at diagnosis of prostate cancer, by population group.
View article: Table S12 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S12 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S12 shows hazard ratios for incident prostate cancer diagnosis among men with HIV compared to men without HIV.
View article: Figure 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Figure 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Prostate cancer diagnosis rates by age and HIV status. The figure shows estimated prostate cancer diagnosis rates per 100,000 person-years by age (years) among men with and without HIV. The shaded areas represent 95% CIs.
View article: Figure 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Figure 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Selection of study population. The flow diagram shows the number of individuals who were excluded from the analysis and the reasons for exclusion.
View article: Table S3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S3 shows the median prostate specific antigen (PSA) levels in men with and without HIV.
View article: Figure 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Figure 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Selection of study population. The flow diagram shows the number of individuals who were excluded from the analysis and the reasons for exclusion.
View article: Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S11 shows hazard ratios for prostate cancer diagnosis, restricting to men with an elevated prostate specific antigen test result (>4 ng/mL) followed by a prostate biopsy.
View article: Table S5 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S5 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S5 shows characteristics at diagnosis of prostate cancer, by population group.
View article: Table S8 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S8 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S8 shows hazard ratios for prostate cancer diagnosis, excluding men with HIV without Aid for AIDS registration.
View article: Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S10 shows hazard ratios for prostate cancer diagnosis, restricting to men with at least one prostate specific antigen test.
View article: Data from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Data from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Background:Several studies have found lower prostate cancer diagnosis rates among men with human immunodeficiency virus (HIV; MWH) than men without HIV but reasons for this finding remain unclear.Methods:We used claims data from a South Af…
View article: Table S9 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S9 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S9 shows hazard ratios for prostate cancer diagnosis, with no left-truncation at first HIV indicator.
View article: Table 2 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table 2 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Rate or HR for PSA testing, prostate biopsies, prostate biopsies in men with elevated PSA, and prostatitis diagnosis.
View article: Table 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table 1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Cohort characteristics by HIV status and overall.
View article: Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S10 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S10 shows hazard ratios for prostate cancer diagnosis, restricting to men with at least one prostate specific antigen test.
View article: Table S13 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S13 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S13 shows hazard ratios for the association of different factors with an incident prostate cancer diagnosis, including men with a single C61 ICD-10 code.
View article: Figure S1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Figure S1 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Figure S1 shows hazard ratios for prostate cancer diagnosis over follow-up time.
View article: Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S6 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S6 shows rate ratios for prostate specific antigen (PSA) testing and prostate biopsies, excluding HIV positive men not in Aid for AIDS registration.
View article: Data from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Data from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Background:Several studies have found lower prostate cancer diagnosis rates among men with human immunodeficiency virus (HIV; MWH) than men without HIV but reasons for this finding remain unclear.Methods:We used claims data from a South Af…
View article: Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S11 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S11 shows hazard ratios for prostate cancer diagnosis, restricting to men with an elevated prostate specific antigen test result (>4 ng/mL) followed by a prostate biopsy.
View article: Table 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table 3 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Hazard ratios for the association of different factors with an incident prostate cancer diagnosis.
View article: Table S13 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S13 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S13 shows hazard ratios for the association of different factors with an incident prostate cancer diagnosis, including men with a single C61 ICD-10 code.
View article: Table S7 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S7 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S7 shows rate ratios for prostate specific antigen testing (PSA) and prostate biopsies, with no left-truncation at first HIV positive marker.
View article: Table S4 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study
Table S4 from Prostate Cancer Diagnosis Rates among Insured Men with and without HIV in South Africa: A Cohort Study Open
Table S4 shows characteristics at diagnosis of prostate cancer, by HIV status and overall.